{"id":"W2596458707","doi":"10.1200/jco.2009.27.15_suppl.3580","title":"Clinical, pharmacokinetic (PK), and pharmacodynamic findings from a phase I trial of an Eg5 inhibitor (AZD4877) in patients with refractory acute myeloid leukemia (AML)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mucositis; Pharmacodynamics; Pharmacokinetics; Internal medicine; Myeloid leukemia; Refractory (planetary science); Bone marrow; Gastroenterology; Myeloid; Toxicity; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001190244,0.00109089,0.001277662,0.0003704459,0.0003118692,0.0006639181,0.0005715281,0.0006683038,0.001371852],"category_scores_gemma":[0.001224399,0.0003791485,0.0005976685,0.000353403,0.000839858,0.0005809881,0.0002570837,0.001951063,0.0003964875],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008404055,"about_ca_system_score_gemma":0.0007170652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006802337,"about_ca_topic_score_gemma":0.001526879,"domain_scores_codex":[0.9996721,0.000147683,0.00002235024,0.000049545,0.00003792474,0.0000703824],"domain_scores_gemma":[0.9992886,0.0002112482,0.0001476253,0.00004880106,0.00002807082,0.0002756128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5364658,0.06127933,0.02806767,0.0009874277,0.001732746,0.001418268,0.001161888,0.01242857,0.1544986,0.0005810002,0.006065619,0.195313],"study_design_scores_gemma":[0.2434043,0.6640945,0.06061404,0.00005568277,0.001282988,0.001559628,0.0001265784,0.004411623,0.01831504,0.0003803434,0.005683617,0.00007160413],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976648,0.0008551364,0.0002217654,0.0001660896,0.00001816051,0.0002524899,0.0002339061,0.00002886639,0.0005587994],"genre_scores_gemma":[0.9968594,0.0007124766,0.0005505828,0.0002750116,0.00008051637,0.0002796553,0.0007113089,0.00001228606,0.0005186964],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001371852,"threshold_uncertainty_score":0.006294668,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05622018853724779,"score_gpt":0.4726576236598117,"score_spread":0.4164374351225639,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}